Company Analysis American Healthcare REIT, Inc.
1. Summary
Advantages
- The stock's return over the last year (49.28%) is higher than the sector average (-11.99%).
Disadvantages
- Price (42.67 $) is higher than fair price (4.24 $)
- Dividends (2.68%) are below the sector average (3.55%).
- Current debt level 41.68% has increased over 5 years from 40.8%.
- The company's current efficiency (ROE=-2.14%) is lower than the sector average (ROE=8.03%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
American Healthcare REIT, Inc. | Real Estate | Index | |
---|---|---|---|
7 days | -0.9% | -6.3% | 0.8% |
90 days | 12.5% | -0.9% | 11% |
1 year | 49.3% | -12% | 16.1% |
AHR vs Sector: American Healthcare REIT, Inc. has outperformed the "Real Estate" sector by 61.26% over the past year.
AHR vs Market: American Healthcare REIT, Inc. has outperformed the market by 33.21% over the past year.
Stable price: AHR is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: AHR with weekly volatility of 0.9476% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (42.67 $) is higher than the fair price (4.24 $).
Price is higher than fair: The current price (42.67 $) is 90.1% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (-139.75) is lower than that of the sector as a whole (84.53).
P/E vs Market: The company's P/E (-139.75) is lower than that of the market as a whole (51.19).
4.3. P/BV
P/BV vs Sector: The company's P/BV (1.61) is higher than that of the sector as a whole (-6.42).
P/BV vs Market: The company's P/BV (1.61) is lower than that of the market as a whole (18.13).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (1.79) is lower than that of the sector as a whole (7.29).
P/S vs Market: The company's P/S indicator (1.79) is lower than that of the market as a whole (27.99).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (17.46) is lower than that of the sector as a whole (19.02).
EV/Ebitda vs Market: The company's EV/Ebitda (17.46) is lower than that of the market as a whole (36.56).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -363.75% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-363.75%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-6.71%).
5.4. ROE
ROE vs Sector: The company's ROE (-2.14%) is lower than that of the sector as a whole (8.03%).
ROE vs Market: The company's ROE (-2.14%) is lower than that of the market as a whole (34.77%).
5.5. ROA
ROA vs Sector: The company's ROA (-0.8342%) is lower than that of the sector as a whole (3.03%).
ROA vs Market: The company's ROA (-0.8342%) is lower than that of the market as a whole (11.49%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (7.36%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (10.03%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 2.68% is below the average for the sector '3.55%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 2.68% has been steadily paid over the past 7 years, DSI=1.
Weak dividend growth: The company's dividend yield 2.68% has been growing weakly or stagnant over the past 5 years. Growth over only 2 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription